The PRINTEMPS study: protocol of a cluster-randomized controlled trial of the local promotion of a smartphone application and associated website for the prevention of suicidal behaviors in the adult general population in France

Coralie Gandré, Anaïs Le Jeannic, Marie-Amélie Vinet, Kathleen Turmaine, Philippe Courtet, Jean-Luc Roelandt, Guillaume Vaiva, Bruno Giraudeau, Corinne Alberti, Karine Chevreul, Coralie Gandré, Anaïs Le Jeannic, Marie-Amélie Vinet, Kathleen Turmaine, Philippe Courtet, Jean-Luc Roelandt, Guillaume Vaiva, Bruno Giraudeau, Corinne Alberti, Karine Chevreul

Abstract

Background: Suicide constitutes a cause of death which could be prevented by e-health programs accessible to the general population. Effective promotion has the potential to maximize the uptake of such programs. However, few e-health programs have been combined with promotion campaigns. The primary objective of this trial is to assess the effectiveness of a tailored promotion, at a local level, of a mobile application and website offering evidence-based content for suicide prevention (the StopBlues program), and to compare the effectiveness of two types of local promotion in terms of their impact on suicidal acts. Secondary objectives focus on the effectiveness of the promotion in terms of the intensity of utilization of the StopBlues program, help-seeking behaviors and the level of psychological impairment of program users.

Methods/design: This is a three-arm, parallel-group, cluster-randomized controlled trial, with before-and-after observation. Thirty-four clusters, corresponding to geographical areas sharing a common local authority in France, will be included. They will be randomly assigned to one of the following arms with a ratio of 1:1:1: a control group; a basic promotion group in which promotion of the StopBlues program will be done by local authorities; and an intensified promotion group in which basic promotion will be supplemented by an additional one in a general practitioner's waiting room. The primary outcome measure will be the number of suicidal acts within each cluster over a 12-month period following the launch of the intervention. Baseline data will be collected for each cluster over the 12-month period prior to the trial. Secondary outcomes will include length of use of the StopBlues program, measures of help-seeking behaviors and level of psychological distress among users of the program, as well as the cost-effectiveness and budgetary impact of its promotion. A more sustained promotion by local authorities will also be implemented after 12 months in the control group and assessed using the same outcome measures.

Discussion: This research should contribute to the sparse evidence base regarding the promotion of e-health programs and will support the wider delivery of the intervention evaluated if proven effective.

Trial registration: ClinicalTrials.gov, ID: NCT03565562. Registered on 11 June 2018.

Keywords: E-health; General population; Help-seeking; Intervention; Local authorities; Mental health; Prevention; Promotion; Psychological distress; Suicide.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Timeline cluster tool of the intervention

References

    1. World Health Organization . Preventing suicide: a global imperative [Internet] Geneva: World Health Organization; 2014.
    1. Organization for Economic Co-operation and Development . “Suicide” in health at a glance 2011: OECD indicators. Paris: Organization for Economic Co-operation and Development; 2011.
    1. Mouquet M-C, Bellamy V. Suicides et tentatives de suicide en France. Etude et Résultats. 2006.
    1. Observatoire National du Suicide. Suicide . Etat des lieux des connaissances et perspectives de recherche? Paris: Observatoire National du Suicide; 2014.
    1. Beck F, Guignard R, Du Roscoät E, Saïas T. Tentatives de suicide et pensées suicidaires en France en 2010. Bull Epidémiol Hebd. 2010, 47:488–92.
    1. O’Dea D, Tucker S. The cost of suicide to society. Wellington: Ministry of Health; 2005.
    1. Kennelly B. The economic cost of suicide in Ireland. Crisis. 2007;28:89–94.
    1. Le Jeannic A, Vinet M, Quelen C, Lefèvre T, Clément M, Gervaix J, et al. The economic burden of suicide in France in 2009. Submitted.
    1. Shepard DS, Gurewich D, Lwin AK, Reed GA, Silverman MM. Suicide and suicidal attempts in the United States: costs and policy implications. Suicide Life Threat Behav. 2016;46:352–362.
    1. World Health Organization . Mental health action plan 2013–2020. Geneva: World Health Organization; 2013.
    1. World internet users statistics usage and world population stats [Internet]. Accessed on 27 Feb 2014]. Available from: .
    1. IC4D 2012 . Information and communications for development: maximizing mobile [Internet] 2012.
    1. Atkinson NL, Saperstein SL, Pleis J. Using the internet for health-related activities: findings from a national probability sample. J Med Internet Res. 2009;11:e4.
    1. Dickerson S, Reinhart AM, Feeley TH, Bidani R, Rich E, Garg VK, et al. Patient Internet use for health information at three urban primary care clinics. J Am Med Inform Assoc. 2004;11:499–504.
    1. Fox S. The social life of health information. Washington DC: Pew Internet and American Life Project; 2009.
    1. Powell J, Clarke A. Internet information-seeking in mental health: population survey. Br J Psychiatry J Ment Sci. 2006;189:273–277.
    1. Berger M, Wagner TH, Baker LC. Internet use and stigmatized illness. Soc Sci Med. 2005;61:1821–1827.
    1. Taylor-Rodgers E, Batterham PJ. Evaluation of an online psychoeducation intervention to promote mental health help seeking attitudes and intentions among young adults: randomised controlled trial. J Affect Disord. 2014;168:65–71.
    1. Larsen ME, Nicholas J, Christensen H. A systematic assessment of smartphone tools for suicide prevention. PLoS One. 2016;11:e0152285.
    1. De Jaegere E, Portzky G, van den Berg M, Wallyn S. Ethical guidelines for technology-based suicide prevention programmes WP 5. Euregenas: Unit for Suicide Research, Ghent University; 2013.
    1. MasterMind Consortium. Policy recommendations based on MasterMind results. Available from: .
    1. Coppens E, Van Audenhove C, Scheerder G, Arensman E, Coffey C, Costa S, et al. Public attitudes toward depression and help-seeking in four European countries baseline survey prior to the OSPI-Europe intervention. J Affect Disord. 2013;150:320–329.
    1. Gronholm PC, Henderson C, Deb T, Thornicroft G. Interventions to reduce discrimination and stigma: the state of the art. Soc Psychiatry Psychiatr Epidemiol. 2017;52:249–258.
    1. Thornicroft C, Wyllie A, Thornicroft G, Mehta N. Impact of the “Like Minds, Like Mine” anti-stigma and discrimination campaign in New Zealand on anticipated and experienced discrimination. Aust N Z J Psychiatry. 2014;48:360–370.
    1. Allen J, Mohatt G, Fok CCT, Henry D, People Awakening Team Suicide prevention as a community development process: understanding circumpolar youth suicide prevention through community level outcomes. Int J Circumpolar Health. 2009;68:274–291.
    1. Bean G, Baber KM. Connect: an effective community-based youth suicide prevention program. Suicide Life Threat Behav. 2011;41:87–97.
    1. Walker RL, Ashby J, Hoskins OD, Greene FN. Peer-support suicide prevention in a non-metropolitan U.S. community. Adolescence. 2009;44:335–346.
    1. Scott A, Guo B. For which strategies of suicide prevention is there evidence of effectiveness? [Internet] Copenhagen: WHO Regional Office for Europe; 2012.
    1. Ono Y, Sakai A, Otsuka K, Uda H, Oyama H, Ishizuka N, et al. Effectiveness of a multimodal community intervention program to prevent suicide and suicide attempts: a quasi-experimental study. PLoS One. 2013;8:e74902.
    1. Székely A, Konkolÿ Thege B, Mergl R, Birkás E, Rózsa S, Purebl G, et al. How to decrease suicide rates in both genders? An effectiveness study of a community-based intervention (EAAD) PLoS One. 2013;8:e75081.
    1. Pearson A, Saini P, Da Cruz D, Miles C, While D, Swinson N, et al. Primary care contact prior to suicide in individuals with mental illness. Br J Gen Pract J R Coll Gen Pract. 2009;59:825–832.
    1. Eldridge SM, Ashby D, Feder GS. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials Lond Engl. 2005;2:91–98.
    1. Frounfelker RL, Ben-Zeev D, Kaiser SM, O’Neill S, Reedy W, Drake RE. Partnering with mental health providers: a guide for services researchers. J Ment Health. 2012;21:469–477.
    1. Caille A, Kerry S, Tavernier E, Leyrat C, Eldridge S, Giraudeau B. Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ. 2016;354:i4291.
    1. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–207.
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
    1. Gulliford MC, Adams G, Ukoumunne OC, Latinovic R, Chinn S, Campbell MJ. Intraclass correlation coefficient and outcome prevalence are associated in clustered binary data. J Clin Epidemiol. 2005;58:246–251.
    1. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: Template for Intervention Description and Replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
    1. Chevreul K, Berg Brigham K, Durand-Zaleski I, Hernandez-Quevedo C. France. Health system review. Health Syst Transit. 2015;17(3):1–218.
    1. Agence technique de l’information sur l’hospitalisation. PMSI-MCO. Présentation [Internet]. Accessed on 11 Sep 2019. Available from: .
    1. Santé Publique France. Réseau OSCOUR® – Organisation de la surveillance coordonnée des urgences [Internet]. Accessed on 11 Sep 2019. Available from: .
    1. Ware J, Kolinski M, Keller S. How to score the SF-12 physical and mental health summaries: a user’s manual. The Health Institute, New England Medical Centre: Boston; 1995.
    1. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859.
    1. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171–1178.
    1. Wilson C, Deane F, Ciarrochi J, Rickwood D. Measuring help-seeking intentions: properties of the General Help Seeking Questionnaire. Can J Couns. 2005;39:15–28.
    1. Goldberg D, Williams P. A user’s guide to the General Health Questionnaire. NFER-Nelson, Windsor, Berks, 1988.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
    1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–1097.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.
    1. Afzali M, Birmes P, Vautier S. Evidence-based Ordering of MINI suicidality module’s response profiles: application to SMPG data. [Internet] 2014.
    1. Cuéllar-Flores I, Sánchez-López MP, Limiñana-Gras RM, Colodro-Conde L. The GHQ-12 for the assessment of psychological distress of family caregivers. Behav Med. 2014;40:65–70.
    1. Salama-Younes M, Montazeri A, Ismaïl A, Roncin C. Factor structure and internal consistency of the 12-item General Health Questionnaire (GHQ-12) and the Subjective Vitality Scale (VS), and the relationship between them: a study from France. Health Qual Life Outcomes. 2009;7:22.
    1. Norton J, de Roquefeuil G, David M, Boulenger J-P, Ritchie K, Mann A. Prevalence of psychiatric disorders in French general practice using the Patient Health Questionnaire: comparison with GP case-recognition and psychotropic medication prescription. L’Encéphale. 2009;35:560–569.
    1. Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, (CSRG) Canadian Scleroderma Research Group Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLoS One. 2012;7:e52028.
    1. Micoulaud-Franchi J-A, Lagarde S, Barkate G, Dufournet B, Besancon C, Trébuchon-Da Fonseca A, et al. Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Epilepsy Behav. 2016;57:211–216.
    1. Donker T, van Straten A, Marks I, Cuijpers P. Quick and easy self-rating of Generalized Anxiety Disorder: Validity of the Dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res. 2011;188:58–64.
    1. Fann JR, Berry DL, Wolpin S, Austin-Seymour M, Bush N, Halpenny B, et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology. 2009;18:14–22.
    1. van Ballegooijen W, Riper H, van Straten A, Kramer J, Conijn B, Cuijpers P. The effects of an internet based self-help course for reducing panic symptoms – Don’t Panic Online: study protocol for a randomised controlled trial. Trials. 2011;12:75.
    1. Furnham A, Cheng H. GHQ score changes from teenage to young adulthood. J Psychiatr Res. 2019;113:46–50.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci. 1979;134:382–389.
    1. Verbeke G. Linear mixed models for longitudinal data. New York: Springer; 2000.
    1. The Ottawa statement on the ethical design and conduct of cluster randomized trials [Internet]. Accessed on 27 Nov 2019. Available from: .
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
    1. Schulz KF, Altman DG, Moher D, CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
    1. Hegerl U, Maxwell M, Harris F, Koburger N, Mergl R, Székely A, et al. Prevention of suicidal behaviour: results of a controlled community-based intervention study in four European countries. PLoS One. 2019;14:e0224602.
    1. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.
    1. Byng R, Norman I, Redfern S, Jones R. Exposing the key functions of a complex intervention for shared care in mental health: case study of a process evaluation. BMC Health Serv Res. 2008;8:274.
    1. Villeval M, Bidault E, Shoveller J, Alias F, Basson J-C, Frasse C, et al. Enabling the transferability of complex interventions: exploring the combination of an intervention’s key functions and implementation. Int J Public Health. 2016;61:1031–1038.
    1. Hamilton AB, Cohen AN, Glover DL, Whelan F, Chemerinski E, McNagny KP, et al. Implementation of evidence-based employment services in specialty mental health. Health Serv Res. 2013;48:2224–2244.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅